Terapet SA and The Politecnico di Milano – Dipartimento di Elettronica, Informazione e Bioingegneria are pleased to announce that they have entered a Research and Development partnership for the coming three years
Geneva, June 1st, 2021 Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer, more precise, and time-saving proton therapy for cancer treatment, announced today the start of a new Research…
learn more